{"id":353723,"date":"2026-02-24T12:40:11","date_gmt":"2026-02-24T12:40:11","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/353723\/"},"modified":"2026-02-24T12:40:11","modified_gmt":"2026-02-24T12:40:11","slug":"helfi-launches-new-clinical-reporting-tool-to-support-2-8-million-uk-fibromyalgia-patients","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/353723\/","title":{"rendered":"Helfi Launches New Clinical Reporting Tool to Support 2.8 Million UK Fibromyalgia Patients"},"content":{"rendered":"

\"CEO<\/a><\/p>\n

CEO at Helfi.no, Elsa Braadland<\/p>\n

\"Professor<\/a><\/p>\n

Professor Egil Fors<\/p>\n

\"Nina<\/a><\/p>\n

Nina Melhus, Certified Oxygen Advantage Advanced Breathing Instructor<\/p>\n

Fibromyalgia is a real somatic condition characterized by central sensitization\u2014where the nervous system is stuck in high alert. It is not a psychological disorder.\u201d<\/b><\/p>\n

\u2014 Professor Egil Fors<\/p>\n

LONDON, UNITED KINGDOM, February 24, 2026 \/EINPresswire.com<\/a>\/ — For the estimated 2.8 million people in the UK living with fibromyalgia<\/a>, the biggest hurdle to recovery isn\u2019t just the pain\u2014it\u2019s the “communication gap” in the doctor\u2019s office. Today, Norwegian health-tech company Helfi announces a new clinical approach to help patients turn “brain fog<\/a>” into hard data, ending the era of “medically unexplained symptoms.”<\/p>\n

A Neurological Reality, Not a Psychological Puzzle<\/p>\n

Many patients still face the outdated stigma that their pain is “all in their head.” Professor Egil Fors, a leading expert in pain medicine and advisor to Helfi, is clear:<\/p>\n

\u201cFibromyalgia is a real somatic condition characterized by central sensitization\u2014where the nervous system is stuck in high alert. It is not a psychological disorder,\u201d says Professor Fors. \u201cThe problem is that during a standard 10-minute GP consultation, it\u2019s impossible for a patient to accurately report weeks of fluctuating symptoms. Without data, the doctor is guessing.\u201d<\/p>\n

Closing the Data Gap<\/p>\n

Helfi solves this by providing a “digital bridge” between the patient and the GP. By logging daily patterns of sleep, stress, and pain, the app generates a structured clinical report.<\/p>\n

\u201cWe are moving the conversation from \u2018I feel\u2019 to \u2018here is the evidence\u2019,\u201d says Elsa Braadland, CEO of Helfi. \u201cWhen a patient can show their doctor a clear correlation between activity levels and pain flares, it creates a professional alliance. The GP gets the insights they need to make better decisions, and the patient finally feels heard.\u201d<\/p>\n

The “Bio-hack” for a Hyper-active Nervous System<\/p>\n

Beyond data, Helfi integrates practical tools to help patients regulate the nervous system Professor Fors describes. Nina Melhus, a certified Oxygen Advantage instructor, highlights the role of functional breathing.<\/p>\n

\u201cMany chronic pain<\/a> sufferers develop dysfunctional breathing patterns that keep them in a state of \u2018fight or flight\u2019,\u201d Melhus explains. \u201cBy using the LSD method (Light, Slow, Deep), patients can actually signal their nervous system to calm down. It\u2019s a physiological tool for mastery that helps clear the \u2018brain fog\u2019 often associated with fibromyalgia.\u201d<\/p>\n

A Tool for Systemic Change<\/p>\n

In a NHS under extreme pressure, Helfi provides a solution that benefits both sides of the desk. By empowering the “patient-detective” with objective data and self-regulation tools, Helfi aims to reduce the number of inconclusive appointments and improve long-term outcomes for chronic pain sufferers.<\/p>\n

About Helfi<\/p>\n

Helfi is a Norwegian health-tech company dedicated to creating digital mastery tools for patients with chronic conditions. Its mission is to bridge the gap between patient and clinician with superior, data-driven insight. Learn more at https:\/\/www.helfi.no\/en<\/a>.<\/p>\n

About Professor Egil Fors<\/p>\n

Professor Egil Fors is a medical doctor and a leading researcher in pain medicine based in Norway. His work focuses extensively on the neurological mechanisms behind “invisible” illnesses like fibromyalgia. As a member of Helfi\u2019s clinical advisory board, he advocates for evidence-based treatments that foster a strong alliance between patients and the healthcare system.<\/p>\n

About Nina Melhus<\/p>\n

Nina Melhus is a certified Oxygen Advantage Advanced Breathing Instructor. Specialising in functional breathing for nervous system regulation, she helps patients manage chronic pain, fatigue, and stress through the LSD (Light, Slow, Deep) method. She serves as an advisor to Helfi on lifestyle-based recovery strategies.<\/p>\n

Elsa Braadland
Helfi.no\/en (Valori Care AS)
+47 948 70 220
email us here<\/a>
Visit us on social media:
LinkedIn<\/a>
Instagram<\/a>
Facebook<\/a>
YouTube<\/a><\/p>\n

Fibromyalgia Explained: Expert Doctor Reveals Truths & Misconceptions<\/p>\n

\n

\n Legal Disclaimer:\n<\/p>\n

\n EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
\n for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
\n article. If you have any complaints or copyright issues related to this article, kindly contact the author above.\n<\/p>\n

\"\"<\/p>\n

You just read:<\/p>\n

News Provided By<\/p>\n

\n February 24, 2026, 11:48 GMT\n <\/p>\n

\n
EIN Presswire’s priority is author transparency. We do our best to weed out false and misleading content. The content above is
\nthe sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.\n <\/p>\n